The Coalition of State Bioscience Institutes (CSBI) joined InnovATEBIO at National Summit to Address Booming Bioscience Industry’s Talent Needs

Summit convened diverse stakeholders in a state ecosystem approach aimed at meeting industry’s urgent workforce gaps

June 30, 2023 | WASHINGTON–( BUSINESS WIRE )–Coalition of State Bioscience Institutes (CSBI) and InnovATEBIO convened a national Summit this week at the National Academies of Sciences in Washington, D.C., tasked with developing workforce strategies designed to sustain U.S. leadership in life sciences innovation. Both national organizations and their multi-state members helped to comprise over 250 attendees for the National Science Foundation- (NSF-)supported  Envisioning the Next Bioscience Workforce Summit , which brought together thought leaders from industry, academia, and government to forecast the continuing wave of discoveries and corresponding talent needs from the industry’s biopharmaceutical, biomedical device, bioprocessing, bioengineering, synthetic biology, and food production subsectors.

INNOVATEBIO + CSBI logo lockup

The first-of-its-kind assembly of diverse public and private stakeholders were brought together by InnovATEBIO, an NSF-funded National Advanced Technology Education Center that supports biotechnology education through its robust network of community colleges, and CSBI, a national coalition of bioscience trade associations and institutes who are committed to delivering industry-led workforce development programs. The collaboration between CSBI and InnovATEBIO has intensified over the last five years as part of an effort to address an outsized demand for talent by the life sciences industry and to open access to careers for a broad and diverse talent base.

Inspired by the innovation forecasts from leaders from the industry’s diverse segments, the Summit’s second day catalyzed state teams, comprised of stakeholders from industry, academia and workforce and economic development organizations, to collaborate on strategic solutions to address workforce gaps in their states.

“The bioscience industry’s workforce challenges are too urgent for any single stakeholder to try and address alone,” said Linnea Fletcher, Executive Director of the InnovATEBIO National Biotech Education Center. “We know that some states are doing an admirable job of bringing their community college and other academic partners together with industry, trade associations and governmental agencies to develop targeted programs that both meet and stay abreast of the industry’s rapidly evolving talent needs. We hope the Summit and its aftermath will provide more states with tools to develop similar strategic collaborations that will address gaps in their own states, a clear win-win for the industry and the highly trained students coming out of our ATE and other programs.”

“What I don’t think many recognize is how significantly many of these ATE and other academic programs can – and are – rapidly responding to urgent calls from bioscience employers for highly skilled technicians,” said Liisa Bozinovic, CSBI Chair and Executive Director of the Oregon Bioscience Association. “These programs are not only meeting companies’ immediate talent needs, but also offering a diverse set of students an accessible and rewarding pathway with multiple options for career and educational growth. That is what we sought to do with this Summit – to help more states develop the partnerships and funding to address gaps in their own regions.”

InnovATEBIO and its partners will continue to support the work of the state teams in the aftermath of the Summit to both broaden and deepen this important work.

For additional information on the Summit, click  here.

About the Coalition for State Biotech Institutes (CSBI)

The Coalition for State Biotech Institutes is dedicated to ensuring America’s leadership in bioscience innovation by delivering industry-led life sciences education and workforce development programs through a nationally coordinated effort. Programs are uniquely positioned for the life sciences industry to deliver, replicable in states across the U.S., extensible to other STEM industry sectors and are fully aligned with Next Generation Science Standards (NGSS). Learn more at  www.csbioinstitutes.org  where you can download our  2023 Life Science Workforce Trends Report.

About InnovATE BIO , the National Biotechnology Education Center:  InnovATE BIO  is supported by a five-year Advanced Technical Education (ATE) grant to advance biotechnology technician education nationally through cutting-edge professional training for instructors and share the best practices among community college programs, administrators, trade organizations, and industry. The Center seeks to develop a collaborative infrastructure that supports innovation and promptly addresses the needs of the biotechnology community. InnovATE BIO  aims to coordinate ATE-funded biotechnology projects to identify opportunities to generate partnerships and collaborations that will accelerate innovation in biotechnology education. In addition to these efforts, it seeks to monitor and address emerging biotechnology industry and technician workforce trends.

Follow Innov ATEBIO  on  Facebook ,  LinkedIn , and  Twitter  at #InnovATEBIO to stay current on biotechnology education in community colleges. View posts at #EnvisioningBioscience for the Envisioning the Next Bioscience Workforce Summit.

Contacts

Maria Thacker, Georgia Bio
mthacker@gabio.org
404-920-2042

Georgia Life Sciences Joins National Coalition Urging Congressional Action on Key Innovation Policies

December 10, 2025
Georgia Life Sciences has joined 43 state and regional life sciences organizations in signing a national Council of State Bioscience Associations (CSBA) letter calling on Congress to take immediate action on three bipartisan policy priorities that are essential to sustaining U.S. leadership in biomedical innovation and supporting patients nationwide. With Congress back in session and several critical programs at risk of expiring, the letter urges congressional leaders to advance the following provisions without delay: 1. Reauthorize the Rare Pediatric Disease Priority Review Voucher (PPRV) Program The PPRV program has been instrumental in incentivizing the development of therapies for children with rare and life-threatening conditions. Its lapse threatens to slow or halt research that families across the country are counting on. 2. Extend the SBIR/STTR Programs The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs provide crucial early-stage capital for emerging biotech and medtech companies—many of them in Georgia. Without reauthorization, hundreds of innovative small businesses face uncertainty, jeopardizing new therapies, diagnostics, and technologies in the pipeline, 3. Advance PBM Transparency Reforms Greater transparency and accountability within pharmacy benefit manager (PBM) practices are needed to ensure that savings reach patients and employers. Reforming PBM operations is essential to strengthening access and affordability across the healthcare system. A Unified Message from the Life Sciences Community The sign-on letter reflects broad, bipartisan alignment across the national life sciences ecosystem: researchers, entrepreneurs, investors, patient advocates, and state associations all share a common message— these programs underpin America’s global competitiveness and are vital to patients who rely on continued scientific progress. Georgia Life Sciences has shared the letter with members of Georgia’s congressional delegation and will continue engaging with policymakers to emphasize the importance of swift action.

GLS Joins Georgia Partners in Calling for Federal PBM Reform

December 7, 2025
Georgia Life Sciences is proud to stand with patient advocates, providers, and employers across the state in urging Congress to take meaningful action on pharmacy benefit manager (PBM) reform. We recently signed on to a joint letter to Georgia’s Congressional Delegation stressing the urgent need for transparency, fair practices, and policies that ensure savings flow directly to patients.

GLS’ President and CEO, Maria Thacker Goethe in December's issue of Georgia Trend

December 4, 2025
Georgia Life Sciences’ CEO, Maria Thacker Goethe shares her perspective on the value of Georgia’s research universities in this month’s issue of Georgia Trend. “Georgia research institutions have felt a very significant impact from the federal rollbacks, specifically in NIH and NSF funding. Thacker Goethe’s message about the impact of research cuts is simple: Disruption shatters the foundational trust researchers have in grant continuity….” To read the full article, click here .
MORE POSTS